BRAF mutations have been found in melanoma (80–90%), thyroid cancer (60%), colorectal cancer (40%), non-small cell lung cancer (6%), pancreatic cancer (90%), and others4–8,11–13. Here, BRAF is linked to non-small cell lung carcinoma.